Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Revolution Medicines (RVMD) Gains from Investment Securities (2018 - 2025)

Revolution Medicines has reported Gains from Investment Securities over the past 8 years, most recently at $2.1 million for Q3 2025.

  • Quarterly results put Gains from Investment Securities at $2.1 million for Q3 2025, up 25.02% from a year ago — trailing twelve months through Dec 2025 was $34.2 million (down 5.66% YoY), and the annual figure for FY2025 was $2.6 million, down 81.76%.
  • Gains from Investment Securities for Q3 2025 was $2.1 million at Revolution Medicines, down from $17.3 million in the prior quarter.
  • Over the last five years, Gains from Investment Securities for RVMD hit a ceiling of $33.9 million in Q4 2024 and a floor of -$81000.0 in Q4 2021.
  • Median Gains from Investment Securities over the past 5 years was $1.3 million (2023), compared with a mean of $4.8 million.
  • Biggest five-year swings in Gains from Investment Securities: tumbled 130.45% in 2021 and later soared 66654.9% in 2024.
  • Revolution Medicines' Gains from Investment Securities stood at -$81000.0 in 2021, then skyrocketed by 2632.1% to $2.1 million in 2022, then crashed by 102.49% to -$51000.0 in 2023, then soared by 66654.9% to $33.9 million in 2024, then plummeted by 93.86% to $2.1 million in 2025.
  • The last three reported values for Gains from Investment Securities were $2.1 million (Q3 2025), $17.3 million (Q2 2025), and $2.9 million (Q1 2025) per Business Quant data.